David Oldach

5.6k citations

88 papers · 4.5k · 2 hit papers · h-index 30

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Oceanography top 2%
- Marine and coastal ecosystems

Papers in

Epidemiology 32
- Hepatitis B Virus Studies 11
- Pneumonia and Respiratory Infections 8
Environmental Chemistry 19
- Marine Toxins and Detection Methods 19

Co-authors: Francis V. Chisari (2 shared papers)Robert Thimme (2 shared papers)Kyong‐Mi Chang (2 shared papers)Stuart C. Ray (1 shared paper)Torstein Tengs (13 shared papers)Holly A. Bowers (12 shared papers)Diane K. Stoecker (4 shared papers)JoAnn M. Burkholder (9 shared papers)
Journals: Journal of Hepatology (10 papers)Environmental Health Perspectives (7 papers)Clinical Infectious Diseases (5 papers)Gastroenterology (4 papers)Hepatology (3 papers)
Partner nations: United States France Germany

In The Last Decade

David Oldach

87 papers receiving 4.2k citations

David Oldach's Hit Papers

align trajectories log scale

Neutralizing antibody response during acute and chronic hepatitis C virus infection 2004 · 340 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Proceedings of the National Academy of Sciences
2001 The Journal of Experimental Medicine

Peers

Countries citing papers authored by David Oldach

Since Specialization

Citations

This map shows the geographic impact of David Oldach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oldach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oldach more than expected).

Fields of papers citing papers by David Oldach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oldach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oldach. The network helps show where David Oldach may publish in the future.

Co-authors

The 25 scholars most cited alongside David Oldach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Oldach Line = papers co-authored together David Oldach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection The Journal of Experimental Medicine ·Robert Thimme, David Oldach, Kyong‐Mi Chang, Carola Steiger, Stuart C. Ray, Francis V. Chisari Hit paper breakdown →	2001	967
2	Neutralizing antibody response during acute and chronic hepatitis C virus infection Proceedings of the National Academy of Sciences ·Carine Logvinoff, Marian Major, David Oldach, Scott Heyward, Andrew H. Talal, Peter Balfe, S M Feinstone, Harrison Alter, Charles M. Rice, Jane A. McKeating Hit paper breakdown →	2004	340
3	Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection Hepatology ·Kyong‐Mi Chang, Robert Thimme, Jacqueline J. Melpolder, David Oldach, Janell Pemberton, Jacquelyn Moorhead-Loudis, John G. McHutchison, Harvey J. Alter, Francis V. Chisari	2001	304
4	Development of Real-Time PCR Assays for Rapid Detection of Pfiesteria piscicida and Related Dinoflagellates Applied and Environmental Microbiology ·Holly A. Bowers, Torstein Tengs, Howard B. Glasgow, JoAnn M. Burkholder, Parke A. Rublee, David Oldach	2000	202
5	Retention of transcriptionally active cryptophyte nuclei by the ciliate Myrionecta rubra Nature ·Matthew D. Johnson, David Oldach, Charles F. Delwiche, Diane K. Stoecker	2007	186
6	Community-Acquired Pneumonia: Impact of Immune Status American Journal of Respiratory and Critical Care Medicine ·Linda M. Mundy, Paul G. Auwaerter, David Oldach, M. L. Warner, ALBERT A. BURTON, Estil Vance, Charlotte A. Gaydos, Jamie Joseph, R Gopalan, Richard D. Moore	1995	173
7	Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates The Lancet ·Lynn M. Grattan, David Oldach, Trish M. Perl, Mark H. Lowitt, Diane L. Matuszak, Curtis W. Dickson, Colleen Parrott, Ritchie C. Shoemaker, C. Lisa Kauffman, Martin P. Wasserman, J. Richard Hebel, Patricia Charache, J. Glenn Morris	1998	132
8	Heteroduplex mobility assay-guided sequence discovery: Elucidation of the small subunit (18S) rDNA sequences of Pfiesteria piscicida and related dinoflagellates from complex algal culture and environmental sample DNA pools Proceedings of the National Academy of Sciences ·David Oldach, Charles F. Delwiche, Kjetill S. Jakobsen, Torstein Tengs, Ernest G. Brown, Jason W. Kempton, Eric F. Schaefer, Holly A. Bowers, Howard B. Glasgow, JoAnn M. Burkholder, Karen A. Steidinger, Parke A. Rublee	2000	119
9	Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection Gastroenterology ·Thomas Berg, Patrick Marcellin, Fabien Zoulim, Bernd Möller, Huy N. Trinh, Sing Chan, Emilio Suárez, Fabien Lavocat, Andrea Snow‐Lampart, David Frederick, J. Sorbel, Katyna Borroto–Esoda, David Oldach, Franck Rousseau	2010	117
10	Phytoplankton and bacterial assemblages in ballast water of U.S. military ships as a function of port of origin, voyage time, and ocean exchange practices Harmful Algae ·JoAnn M. Burkholder, Gustaaf M. Hallegraeff, Gregory C. R. Melia, A. N. Cohen, Holly A. Bowers, David Oldach, Matthew W. Parrow, Michael J. Sullivan, Paul V. Zimba, Elle H. Allen, Carol A. Kinder, Michael A. Mallin	2007	113
11	Abacavir and Mycophenolic Acid, an Inhibitor of Inosine Monophosphate Dehydrogenase, Have Profound and Synergistic Anti-HIV Activity JAIDS Journal of Acquired Immune Deficiency Syndromes ·David M. Margolis, Alonso Heredia, Jariyanart Gaywee, David Oldach, George L. Drusano, Robert R. Redfield	1999	100
12	The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C Hepatology ·Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, D. Séréni, Hartwig Klinker, Christophe Moreno, Jean‐Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns, Graham R. Foster	2011	97
13	SEQUESTRATION, PERFORMANCE, AND FUNCTIONAL CONTROL OF CRYPTOPHYTE PLASTIDS IN THE CILIATE MYRIONECTA RUBRA (CILIOPHORA)¹ Journal of Phycology ·Matthew D. Johnson, Torstein Tengs, David Oldach, Diane K. Stoecker	2006	81
14	RAPHIDOPHYCEAE [CHADEFAUD EX SILVA] SYSTEMATICS AND RAPID IDENTIFICATION: SEQUENCE ANALYSES AND REAL‐TIME PCR ASSAYS¹ Journal of Phycology ·Holly A. Bowers, Carmelo R. Tomas, Torstein Tengs, Jason W. Kempton, Alan J. Lewitus, David Oldach	2006	79
15	USE OF RENAL ALLOGRAFTS FROM DONORS POSITIVE FOR HEPATITIS B CORE ANTIBODY CONFERS MINIMAL RISK FOR SUBSEQUENT DEVELOPMENT OF CLINICAL HEPATITIS B VIRUS DISEASE1 Transplantation ·Robert Madayag, Lynt B. Johnson, Stephen T. Bartlett, Eugene J. Schweitzer, Niel T. Constantine, Robert McCarter, Paul C. Kuo, Susan Keay, David Oldach	1997	70
16	Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study EBioMedicine ·Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine A. Hay, Patrick F. Smith, Frank Engler, Rienk E. Jeeninga, Saskia L. Smits, José Trevejo, Zach Shriver, David Oldach	2019	66
17	Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia Antimicrobial Agents and Chemotherapy ·David Oldach, Kay Clark, Jennifer Schranz, Anita Das, J. Carl Craft, Drusilla Scott, Brian Jamieson, Prabhavathi Fernandes	2013	65
18	SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia Clinical Infectious Diseases ·Thomas M. File, Barbara Rewerska, Violeta Vučinić-Mihailović, Joven Gonong, Anita Das, Kara Keedy, David Taylor, Amanda Sheets, Prabhavathi Fernandes, David Oldach, Brian Jamieson	2016	65
19	Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay Clinical Infectious Diseases ·C A Gaydos, Joseph Eiden, David Oldach, Linda M. Mundy, Paul G. Auwaerter, M. L. Warner, Estil Vance, ALBERT A. BURTON, Thomas C. Quinn	1994	61
20	PCR and FISH Detection Extends the Range of Pfiesteria piscicida in Estuarine Waters ODU Digital Commons (Old Dominion University) ·Parke A. Rublee, Jason W. Kempton, Elena A. Schaefer, JoAnn M. Burkholder, H Glasgow, David Oldach	1999	60

About David Oldach

David Oldach is a scholar working on Epidemiology, Environmental Chemistry, Molecular Biology, Ecology and Oceanography, having authored 88 papers that have together received 4.5k indexed citations. Recurring topics across this work include Marine Toxins and Detection Methods (19 papers), Microbial Community Ecology and Physiology (14 papers), Hepatitis C virus research (13 papers), Marine and coastal ecosystems (12 papers), Protist diversity and phylogeny (12 papers), Hepatitis B Virus Studies (11 papers), Pneumonia and Respiratory Infections (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). The work is most often cited by research in Hepatology (1.6k citations), Oceanography (782 citations), Environmental Chemistry (634 citations), Virology (258 citations) and Epidemiology (1.7k citations). David Oldach has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Francis V. Chisari, Robert Thimme, Kyong‐Mi Chang, Stuart C. Ray, Torstein Tengs, Holly A. Bowers, Diane K. Stoecker, JoAnn M. Burkholder, Matthew D. Johnson and Parke A. Rublee. Their work appears in journals such as Journal of Hepatology, Environmental Health Perspectives, Clinical Infectious Diseases, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

David Oldach

Impact in

Papers in i

In The Last Decade

David Oldach

David Oldach's Hit Papers

Peers

Countries citing papers authored by David Oldach

Fields of papers citing papers by David Oldach

All Works

About David Oldach

Explore authors with similar magnitude of impact

Papers in